• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与无应答者相比,接受升级和对心脏再同步治疗有反应的植入式心脏复律除颤器患者的室性心律失常更少。

Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.

机构信息

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, Leiden, the Netherlands.

出版信息

J Am Coll Cardiol. 2011 Nov 22;58(22):2282-9. doi: 10.1016/j.jacc.2011.08.038.

DOI:10.1016/j.jacc.2011.08.038
PMID:22093504
Abstract

OBJECTIVES

The purpose of this study was to evaluate the impact of upgrading implantable cardioverter-defibrillator (ICD) therapy to cardiac resynchronization therapy (CRT) combined with defibrillator (CRT-D) on the occurrence of ventricular arrhythmia (VA) and appropriate ICD therapies.

BACKGROUND

CRT has been shown to improve left ventricular (LV) systolic function and induce reverse LV remodeling. In addition, it has been hypothesized that CRT may reduce the incidence of VA.

METHODS

Heart failure patients receiving an upgrade from ICD to CRT-D were evaluated. Patients were considered responders to CRT if LV end-systolic volume reduced ≥15% at 6 months of follow-up. Episodes of VA, triggering device therapy (anti-tachycardia pacing and shocks) were recorded before and after upgrade for the overall population. In addition, these outcomes were compared between CRT responders and nonresponders during the follow-up period after CRT response was assessed.

RESULTS

One hundred fifteen patients (93 males [81%], age 65 ± 12 years) were evaluated during a mean follow-up of 54 ± 34 months before CRT-D upgrade and 37 ± 27 months after upgrade. In CRT responders (n = 70), the frequency of VA requiring appropriate device therapy demonstrated a trend toward a decrease from 0.51 ± 0.79 to 0.30 ± 0.59 per patient per year after CRT-D upgrade (p = 0.052). In CRT nonresponders (n = 45), the frequency of VA requiring appropriate device therapy significantly increased from 0.40 ± 0.69 to 1.21 ± 2.53 per patient per year after CRT-D upgrade (p = 0.014).

CONCLUSIONS

After upgrade from ICD to CRT-D, nonresponders to CRT showed a significant increase in VA burden requiring appropriate device therapy.

摘要

目的

本研究旨在评估将植入式心脏复律除颤器(ICD)升级为心脏再同步治疗(CRT)联合除颤器(CRT-D)对室性心律失常(VA)和适当的 ICD 治疗的发生的影响。

背景

CRT 已被证明可改善左心室(LV)收缩功能并诱导 LV 逆重构。此外,有人假设 CRT 可能会降低 VA 的发生率。

方法

评估了从 ICD 升级为 CRT-D 的心力衰竭患者。如果在 6 个月的随访中 LV 收缩末期容积减少≥15%,则认为患者对 CRT 有反应。在升级前后,记录了整个人群的 VA 发作和触发设备治疗(抗心动过速起搏和电击)。此外,在 CRT 反应评估后的随访期间,还比较了 CRT 反应者和无反应者之间的这些结局。

结果

在 CRT-D 升级前平均随访 54±34 个月和升级后 37±27 个月,对 115 名患者(93 名男性[81%],年龄 65±12 岁)进行了评估。在 CRT 反应者(n=70)中,在升级后,需要适当设备治疗的 VA 频率从 CRT-D 升级前的 0.51±0.79 次/患者/年降至 CRT-D 升级后的 0.30±0.59 次/患者/年,呈下降趋势(p=0.052)。在 CRT 无反应者(n=45)中,在升级后,需要适当设备治疗的 VA 频率从 CRT-D 升级前的 0.40±0.69 次/患者/年显著增加至 CRT-D 升级后的 1.21±2.53 次/患者/年(p=0.014)。

结论

从 ICD 升级为 CRT-D 后,对 CRT 无反应者的 VA 负担显著增加,需要适当的设备治疗。

相似文献

1
Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.与无应答者相比,接受升级和对心脏再同步治疗有反应的植入式心脏复律除颤器患者的室性心律失常更少。
J Am Coll Cardiol. 2011 Nov 22;58(22):2282-9. doi: 10.1016/j.jacc.2011.08.038.
2
Impact of upgrade to cardiac resynchronization therapy on ventricular arrhythmia frequency in patients with implantable cardioverter-defibrillators.升级为心脏再同步治疗对植入式心律转复除颤器患者室性心律失常发生率的影响。
J Am Coll Cardiol. 2005 Dec 20;46(12):2258-63. doi: 10.1016/j.jacc.2005.04.067.
3
Reduced atrial tachyarrhythmia susceptibility after upgrade of conventional implanted pulse generator to cardiac resynchronization therapy in patients with heart failure.心力衰竭患者将传统植入式脉冲发生器升级为心脏再同步治疗后房性快速心律失常易感性降低。
J Am Coll Cardiol. 2007 Sep 25;50(13):1246-51. doi: 10.1016/j.jacc.2007.04.096. Epub 2007 Sep 10.
4
Antiarrhythmic effect of reverse ventricular remodeling induced by cardiac resynchronization therapy: the InSync ICD (Implantable Cardioverter-Defibrillator) Italian Registry.心脏再同步治疗诱导的逆向心室重构的抗心律失常作用:InSync ICD(植入式心律转复除颤器)意大利注册研究
J Am Coll Cardiol. 2008 Oct 28;52(18):1442-9. doi: 10.1016/j.jacc.2008.07.043.
5
Effect of cardiac resynchronisation therapy on occurrence of ventricular arrhythmia in patients with implantable cardioverter defibrillators undergoing upgrade to cardiac resynchronisation therapy devices.心脏再同步治疗对接受升级为心脏再同步治疗设备的植入式心脏复律除颤器患者室性心律失常发生情况的影响。
Heart. 2008 Feb;94(2):186-90. doi: 10.1136/hrt.2007.118372. Epub 2007 Aug 29.
6
Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.心脏再同步化治疗对左心室收缩功能不全、植入式心脏复律除颤器适应症及轻度症状性慢性心力衰竭患者疾病进展的影响。
Circulation. 2004 Nov 2;110(18):2864-8. doi: 10.1161/01.CIR.0000146336.92331.D1. Epub 2004 Oct 25.
7
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).植入式心脏除颤器可改善接受心脏再同步治疗的轻度症状性心力衰竭患者的生存率:收缩性左心室功能障碍(REVERSE)重构长期随访分析。
Circ Arrhythm Electrophysiol. 2013 Dec;6(6):1163-8. doi: 10.1161/CIRCEP.113.000570. Epub 2013 Oct 14.
8
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.心脏再同步化治疗改善左心室不同步与收缩功能的关系及其临床转归:MADIT-CRT 试验。
Eur Heart J. 2011 Jul;32(14):1720-9. doi: 10.1093/eurheartj/ehr185. Epub 2011 May 24.
9
Prediction of appropriate defibrillator therapy in heart failure patients treated with cardiac resynchronization therapy.预测心力衰竭患者接受心脏再同步治疗后的合适除颤治疗。
Am J Cardiol. 2010 Jan 1;105(1):105-11. doi: 10.1016/j.amjcard.2009.08.659. Epub 2009 Nov 18.
10
Ventricular tachycardia or ventricular fibrillation occurs less often in patients with left bundle branch block and combined resynchronization and defibrillators than in patients with narrow QRS and conventional defibrillators.与窄 QRS 波和传统除颤器相比,左束支传导阻滞和联合再同步除颤器的患者发生室性心动过速或心室颤动的情况较少。
Europace. 2012 Feb;14(2):224-9. doi: 10.1093/europace/eur307. Epub 2011 Sep 22.

引用本文的文献

1
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy-a nationwide cohort study.年龄分层比较非缺血性心肌病心脏再同步治疗伴或不伴预防性除颤器的预后:一项全国性队列研究。
Europace. 2023 Jul 4;25(7). doi: 10.1093/europace/euad187.
2
Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis.升级右心室起搏器为双心室起搏或传导系统起搏:系统评价和荟萃分析。
Europace. 2023 Mar 30;25(3):1077-1086. doi: 10.1093/europace/euac188.
3
Synchronization of repolarization after cardiac resynchronization therapy: A combined clinical and modeling study.
心脏再同步治疗后的复极同步:一项临床与模型相结合的研究。
J Cardiovasc Electrophysiol. 2022 Aug;33(8):1837-1846. doi: 10.1111/jce.15581. Epub 2022 Jun 11.
4
The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study.血液学指标与心脏再同步治疗反应的相关性:一项单中心研究。
Hippokratia. 2019 Jul-Sep;23(3):118-125.
5
Association left ventricular lead and ventricular arrhythmias after upgrade to cardiac resynchronization therapy in patients with implantable cardioverter defibrillators.在植入式心脏复律除颤器患者升级为心脏再同步治疗后,左心室导联与室性心律失常的关系。
Clin Cardiol. 2019 Jul;42(7):670-677. doi: 10.1002/clc.23192. Epub 2019 May 13.
6
Higher ultrafiltration rate is associated with right ventricular mechanical dispersion.较高的超滤率与右心室机械离散有关。
Anatol J Cardiol. 2019 Mar;21(4):206-213. doi: 10.14744/AnatolJCardiol.2019.26243.
7
Upgrade from ICD to CRT-D: clinical and haemodynamic impact of biventricular pacing in a patient with acquired long QT syndrome.从植入式心律转复除颤器(ICD)升级为心脏再同步化治疗除颤器(CRT-D):双心室起搏对一名获得性长QT综合征患者的临床及血流动力学影响
Open Med (Wars). 2015 Jan 15;10(1):113-118. doi: 10.1515/med-2015-0023. eCollection 2015.
8
Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis.心脏再同步治疗患者中植入式心脏复律除颤器备用的重要性:一项系统评价和荟萃分析。
J Am Heart Assoc. 2015 Nov 6;4(11):e002539. doi: 10.1161/JAHA.115.002539.
9
Impact of myocardial viability assessed by myocardial perfusion imaging on ventricular tachyarrhythmias in cardiac resynchronization therapy.心肌灌注显像评估心肌存活性对心脏再同步治疗中室性心律失常的影响。
J Nucl Cardiol. 2013 Dec;20(6):1049-59. doi: 10.1007/s12350-013-9795-y. Epub 2013 Oct 18.
10
Biventricular / left ventricular pacing in hypertrophic obstructive cardiomyopathy: an overview.肥厚型梗阻性心肌病的双心室/左心室起搏:综述
Indian Pacing Electrophysiol J. 2012 May;12(3):114-23. doi: 10.1016/s0972-6292(16)30503-4. Epub 2012 May 20.